About this trial
The cAPAble study aims to evaluate the impact of an adapted physical activity program on persistent fatigue in patients with inflammatory bowel disease in remission. This multicenter randomized study will include 120 participants. Participants will be randomly assigned to either a 6-month adapted physical activity program or usual care. Fatigue will be assessed using the FACIT-F questionnaire at 6 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Remission according to PRO2 (Patient-Reported Outcome): liquid stool frequency ≤2/day and abdominal pain score ≤1 for Crohn's disease; stool frequency score ≤1 and rectal bleeding score = 0 for ulcerative colitis.
CRP <5 mg/L.
Fecal calprotectin <250 µg/g.
Patients with significant fatigue (FACIT-F score ≤40) persisting for at least 3 months before inclusion, confirmed by two successive FACIT-F questionnaire assessments: the first at the screening visit (M-3), after obtaining informed consent, serving as the baseline value, and the second at the inclusion visit (M0), confirming persistence of fatigue for at least 3 months.
Disqualifiers
Another identified cause of fatigue based on the first-line assessment performed in this context (complete blood count, liver function tests, CRP, blood electrolyte panel, serum creatinine, iron studies, folate, vitamin B12, TSH, fasting blood glucose).
Unstable cardiovascular or respiratory disease.
Patients already meeting the WHO physical activity recommendations before inclusion (IPAQ score ≥1500).
Current pregnancy or pregnancy planned during the study period.
Trial design
Parallel
Treatments tested in this trial
Adapted Physical Activity
BehavioralA 6-month adapted physical activity program tailored to each participant's physical abilities and individual needs. The program consists of 12 one-hour sessions delivered every two weeks, followed by 2 months of telephone follow-up to support participants in maintaining regular physical activity.
Usual Care
Other interventionParticipants will receive usual care according to standard clinical practice.
Treatment groups
Trial outcomes
Primary outcomes
Mean Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) score at 6 months.
Mean Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) score in each study arm at 6 months. The FACIT-F scale ranges from 0 to 52, with higher scores indicating less fatigue and better quality of life.
Secondary outcomes
Fatigue assessed by the FACIT-Fatigue (FACIT-F) score at 3 and 12 months
The FACIT-Fatigue subscale is a 13-item self-administered questionnaire. The total score ranges from 0 to 52; a higher score indicates less fatigue (better outcome). Mean scores are compared between the adapted physical activity arm and the standard care arm.
Quality of life assessed by the Inflammatory Bowel Disease Disability Index (IBD-Disk)
The Inflammatory Bowel Disease Disability Index (IBD-Disk) is a 10-item self-administered instrument. Each item is rated on a numerical scale from 0 to 10, resulting in a total score ranging from 0 to 100. Higher scores indicate greater disability and poorer quality of life. Mean IBD-Disk scores will be compared between the adapted physical activity arm and the standard care arm.
Physical condition assessed by Body weight
Body weight (kg) - mean values are compared between the adapted physical activity arm and the standard care arm.
Physical condition assessed by body mass index
Body mass index (kg/m²) - Mean values are compared between the adapted physical activity arm and the standard care arm.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: